XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $815 | -11.3% | 23,866 | 0.0% | 0.31% | -15.0% |
| Q2 2023 | $919 | -35.8% | 23,866 | -40.3% | 0.37% | -35.0% |
| Q1 2023 | $1,432 | -39.0% | 40,000 | -32.8% | 0.56% | -36.5% |
| Q4 2022 | $2,346 | -99.9% | 59,500 | 0.0% | 0.89% | -2.0% |
| Q3 2022 | $2,148,000 | +18.7% | 59,500 | 0.0% | 0.90% | +18.9% |
| Q2 2022 | $1,810,000 | -11.0% | 59,500 | -10.5% | 0.76% | +17.3% |
| Q1 2022 | $2,033,000 | -24.8% | 66,500 | -23.1% | 0.65% | -29.3% |
| Q4 2021 | $2,702,000 | – | 86,488 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
| GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
| DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
| Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
| Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
| BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |